Clinical Trials

Showing trials with last updates posted in 2017.

NCT01866722 | COMPLETED | NA
560 participants

Not Quite Ready to Quit

Study Type:
INTERVENTIONAL
Last Updated:
2017-07-31
Start Date:
2013-09-30
Completion:
2015-01-10
Conditions
  • Smoking Cessation
Interventions
  • BEHAVIORAL
No Results Yet
NCT01349972 | COMPLETED | PHASE2
172 participants

Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2017-07-31
Start Date:
2011-04-30
Completion:
2014-05-31
Conditions
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Adult Acute Monoblastic Leukemia (M5a)
  • Adult Acute Monocytic Leukemia (M5b)
  • Adult Acute Myeloblastic Leukemia With Maturation (M2)
  • Adult Acute Myeloblastic Leukemia Without Maturation (M1)
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Del(5q)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Adult Acute Myelomonocytic Leukemia (M4)
  • Adult Erythroleukemia (M6a)
  • Adult Pure Erythroid Leukemia (M6b)
  • Secondary Acute Myeloid Leukemia
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page